J. Hisatake

发表

Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survival

S. Tomoyasu, P. Koeffler, T. Nakamaki, 2003, British journal of haematology.

Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.

H. Koeffler, S. Tomoyasu, M. Uskoković, 2001, Blood.

PC‐SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo

H. P. Koeffler, H. Taguchi, J. Hisatake, 2000, The Prostate.

Efficacy and Adverse Effects of Rituximab Combined with a TCOP Regimen in Patients with Untreated Diffuse Large B-cell Lymphoma and Follicular Lymphoma

S. Tomoyasu, T. Nakamaki, J. Hisatake, 2009 .

HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells.

E. Daar, H. Koeffler, H. Taguchi, 2000, Blood.

Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions.

H. Koeffler, M. Uskoković, J. Hisatake, 2000, Journal of medicinal chemistry.

Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response

K. Aihara, J. Hisatake, Yuji Okamoto, 2021, bioRxiv.

5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.

H. Koeffler, S. Tomoyasu, M. Uskoković, 1999, Cancer research.

Cells of Proliferation of Prostate , Breast , and Myeloid Leukemic : A New Class of Potent Inhibitors 3-16-ene-Vitamin D trans 5 , 6-Updated

H. Koeffler, S. Tomoyasu, M. Uskoković, 1999 .

6-trans-16-ene-Vitamin D 3 : A New Class of Potent Inhibitors of Proliferation of Prostate , Breast , and Myeloid Leukemic Cells 1

H. Koeffler, S. Tomoyasu, M. Uskoković, 1999 .

Reversibility of monocytic differentiation of HL-60 cells by 1alpha,25 dihydroxyvitamin D3.

K. Fukuchi, S. Tomoyasu, N. Tsuruoka, 1997, Leukemia research.

Induction of Differentiation and Production of Cytokines of HL-60 Cells by 22-Oxa-1α, 25-Dihydroxyvitamin D 3

S. Tomoyasu, N. Tsuruoka, T. Nakamaki, 1996 .

Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR4.5): The phase 2, multicenter N‐Road study

J. Hisatake, A. Tojo, T. Igarashi, 2020, Cancer medicine.

Methylation of p16 and p15 Genes in Lymphoid Malignancies

N. Tsuruoka, Y. Hamano, J. Hisatake, 1998 .

[Nasopharyngeal natural killer cell lymphoma with pericardial infiltration].

S. Tomoyasu, N. Tsuruoka, J. Hisatake, 1996, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.

M. Carey, H. Koeffler, S. Tomoyasu, 2000, Cancer research.

[Hepatitis-associated aplastic anemia preceded by a hemophagocytic syndrome-like state].

S. Tomoyasu, T. Nakamaki, J. Hisatake, 2003, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies.

E. Williamson, H. Koeffler, C. Miller, 2001, Cancer Research.

24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.

H. Koeffler, M. Uskoković, J. Hisatake, 2001, Cancer research.

Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice.

H. Koeffler, J. Hisatake, A. Norman, 2002, The Journal of clinical investigation.

Effect of cytokines on the proliferation and differentiation of acute promyelocytic leukemia cells: possible relationship to the development of "retinoic acid syndrome".

S. Tomoyasu, N. Tsuruoka, T. Nakamaki, 1994, Anticancer research.